ad 5075 has been researched along with 3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid in 1 studies
Studies (ad 5075) | Trials (ad 5075) | Recent Studies (post-2010) (ad 5075) | Studies (3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid) | Trials (3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid) | Recent Studies (post-2010) (3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid) |
---|---|---|---|---|---|
9 | 0 | 0 | 10 | 0 | 4 |
Protein | Taxonomy | ad 5075 (IC50) | 3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid (IC50) |
---|---|---|---|
Transient receptor potential cation channel subfamily V member 1 | Rattus norvegicus (Norway rat) | 0.0354 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.173 | |
Oxysterols receptor LXR-beta | Homo sapiens (human) | 0.0265 | |
Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 0.0055 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.2875 | |
Oxysterols receptor LXR-alpha | Homo sapiens (human) | 0.0337 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, GD; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Elbrecht, A; Hayes, NS; Leibowitz, MD; Li, Y; Marquis, R; Moller, DE; Mosley, R; Sahoo, SP; Santini, C; Smith, RG; Tanen, M; Tolman, RL; Ventre, J; Wu, MS; Zhang, B; Zhou, G | 1 |
1 other study(ies) available for ad 5075 and 3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid
Article | Year |
---|---|
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Topics: Adipocytes; Animals; Blood Glucose; Cell Differentiation; Cell Line; Diabetes Mellitus, Experimental; Humans; Ligands; Mice; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 1999 |